CIN 2/3
9
4
4
4
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 9 trials
100.0%
+13.5% vs benchmark
11%
1 trials in Phase 3/4
25%
1 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (9)
The Selfie Study- Assessing Novel Markers for Cervical Cancer Screening From Self-collected Samples
Artesunate Vaginal Inserts for the Treatment of Cervical Intraepithelial Neoplasia (CIN2/3)
Safety and Efficacy of Oral Artesunate for Pre-cervical Cancer
5-fluorouracil Following Cervical Intraepithelial Neoplasia Treatment Among HIV-positive Women in East Africa
Assessment of the Effectiveness of TA Versus LEEP for Cervical Cancer Risk Reduction in WLHIV in Mozambique
Predicting Response In Cervical Intraepithelial Neoplasia to Topical Imiquimod Treatment
Thermocoagulation for Treatment of Precancerous Cervical Lesions
Concomitant HPV Vaccination and HPV Screening HPV Infection and Cervical Cancer in Sweden
Vvax001 Cancer Vaccine in (Pre) Malignant Cervical Lesions